C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:C. R. Bard Inc (BCR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011718
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral vascular (PVD) and end-stage renal (ESRD) diseases; urology drainage products, fecal and urinary continence products and urological specialty products; specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters and enteral feeding devices; implanted grafts and fixation devices for hernia and soft tissue repairs and hemostats and surgical sealants. Bard offers its products to hospitals, individual health care professionals, extended care facilities and alternate site facilities. The company conducts its operations in the Americas, Europe, Asia-Pacific, the Middle East and Africa. Bard is headquartered in Murray Hill, New Jersey, the US.

C. R. Bard Inc (BCR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
C. R. Bard Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
C. R. Bard Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
C. R. Bard Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
C. R. Bard Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
C. R. Bard Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
C. R. Bard Acquires Technology from 3DT Holdings 12
Venture Financing 13
Embo Medical Raises USD3.7 Million in Seed Funding 13
Vascular Pathways Secures USD5 Million from Square 1 Bank 14
Vascular Pathways Raises USD5.5 Million in Venture Financing 15
NeoMend Secures US$10 Million In Financing 16
Partnerships 17
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 17
Equity Offering 18
ClearStream Technologies Completes Private Placement For US$2 Million 18
Debt Offering 19
C. R. Bard Raises USD500 Million in Public Offering of 3% Notes Due 2026 19
C. R. Bard Raises USD500 Million in Public Offering of 1.375% Notes Due 2018 20
Acquisition 21
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 21
C. R. Bard Acquires Liberator Medical for USD181 Million 23
C. R. Bard Acquires Embo Medical 25
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 26
C. R. Bard Acquires Vascular Pathways Europe from MVM Life Science Partners 27
C. R. Bard Acquires Vascular Pathways from MVM Life Science Partners 28
C. R. Bard Completes Acquisition Of Rochester Medical For US$262 Million 29
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 31
Davol Completes Acquisition Of Medafor 33
C. R. Bard Acquires Loma Vista Medical 34
C. R. Bard Acquires Neomend, Developer Of Wound Healing Products, For Up To US$165 Million 35
C. R. Bard Acquires Lutonix 37
C. R. Bard Completes Acquisition Of Medivance For US$250 Million 38
C. R. Bard Completes Acquisition Of Clearstream Technologies For US$69 Million 40
Rochester Medical Completes Acquisition Of Laprolan From Fornix BioSciences 42
C. R. Bard Inc – Key Competitors 43
C. R. Bard Inc – Key Employees 44
C. R. Bard Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 51
Financial Announcements 51
Oct 25, 2017: Bard Announces Third Quarter Results 51
Apr 23, 2017: Bard Announces First Quarter Results 53
Jan 26, 2017: Bard Announces Fourth Quarter Results 54
Oct 25, 2016: Bard Announces Third Quarter Results 55
Jul 26, 2016: Bard Announces Second Quarter Results 56
Apr 27, 2016: Bard Announces First Quarter Results 57
Jan 29, 2016: Bard Announces Fourth Quarter Results 58
Legal and Regulatory 59
May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 59
Jan 08, 2016: Seeger Weiss LLP Reports That IVC Filter Lawsuits Against C.R. Bard Have Been Consolidated In A Multidistrict Litigation 60
Product News 61
02/09/2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016 61
Other Significant Developments 62
Apr 06, 2016: SharedClarity Awards Surgical Mesh Contracts for Breast Reconstructive and Hernia Repair Surgeries 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
C. R. Bard Inc, Medical Equipment, Key Facts, 2016 2
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
C. R. Bard Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
C. R. Bard Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
C. R. Bard Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
C. R. Bard Inc, Deals By Market, 2011 to YTD 2017 9
C. R. Bard Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
C. R. Bard Acquires Technology from 3DT Holdings 12
Embo Medical Raises USD3.7 Million in Seed Funding 13
Vascular Pathways Secures USD5 Million from Square 1 Bank 14
Vascular Pathways Raises USD5.5 Million in Venture Financing 15
NeoMend Secures US$10 Million In Financing 16
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB 17
ClearStream Technologies Completes Private Placement For US$2 Million 18
C. R. Bard Raises USD500 Million in Public Offering of 3% Notes Due 2026 19
C. R. Bard Raises USD500 Million in Public Offering of 1.375% Notes Due 2018 20
Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 21
C. R. Bard Acquires Liberator Medical for USD181 Million 23
C. R. Bard Acquires Embo Medical 25
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 26
C. R. Bard Acquires Vascular Pathways Europe from MVM Life Science Partners 27
C. R. Bard Acquires Vascular Pathways from MVM Life Science Partners 28
C. R. Bard Completes Acquisition Of Rochester Medical For US$262 Million 29
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million 31
Davol Completes Acquisition Of Medafor 33
C. R. Bard Acquires Loma Vista Medical 34
C. R. Bard Acquires Neomend, Developer Of Wound Healing Products, For Up To US$165 Million 35
C. R. Bard Acquires Lutonix 37
C. R. Bard Completes Acquisition Of Medivance For US$250 Million 38
C. R. Bard Completes Acquisition Of Clearstream Technologies For US$69 Million 40
Rochester Medical Completes Acquisition Of Laprolan From Fornix BioSciences 42
C. R. Bard Inc, Key Competitors 43
C. R. Bard Inc, Key Employees 44
C. R. Bard Inc, Other Locations 46
C. R. Bard Inc, Subsidiaries 47

★海外企業調査レポート[C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Applied Industrial Technologies Inc (AIT):企業の財務・戦略的SWOT分析
    Applied Industrial Technologies Inc (AIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • CG Power and Industrial Solutions Ltd (CGPOWER):企業の財務・戦略的SWOT分析
    CG Power and Industrial Solutions Ltd (CGPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Microsoft Corporation (MSFT):企業の財務・戦略的SWOT分析
    Microsoft Corporation (MSFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dai-ichi Life Holdings, Inc.:企業のM&A・事業提携・投資動向
    Dai-ichi Life Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dai-ichi Life Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Idemitsu Kosan Co Ltd (5019):石油・ガス:M&Aディール及び事業提携情報
    Summary Idemitsu Kosan Co Ltd (Idemitsu) is an integrated energy company that explores, produces, refines, and sells oil and gas, lubricants, and petroleum products. The company manufactures agricultural chemicals, agricultural materials, and other chemicals. It explores, develops and extracts coal, …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds 2P reserves of 21.4 mmbo and has an oil production of barrels from Blocks in Sultanate of Oman. It also holds onshore explorati …
  • Origin Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Origin Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Origin Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the …
  • Maxim Integrated Products Inc (MXIM):企業の財務・戦略的SWOT分析
    Maxim Integrated Products Inc (MXIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Genomic Vision SA (GV):医療機器:M&Aディール及び事業提携情報
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • Premier Veterinary Group Plc (PVG):企業の財務・戦略的SWOT分析
    Summary Premier Veterinary Group Plc (Premier Veterinary Group) formerly ARK Therapeutics Group Plc, is a veterinary care service provider. The company offers services such as premier pet care plan and premier buying group. Its pet care plan is a preventative healthcare program for dogs, cats, and r …
  • Network Rail Limited:企業の戦略・SWOT・財務分析
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報
    Summary William Demant Holding AS (WDH) is a provider of hearing healthcare solutions that develops, manufactures and distributes products designed to aid people with hearing loss. The company offers hearing devices and implants, diagnostic instruments and personal communication devices. Its product …
  • T-System Inc-医療機器分野:企業M&A・提携分析
    Summary T-System Inc (T-System) is a healthcare service provider that offers clinical, financial, operational, and regulatory solutions. The company offers documentation solutions, which include EV, an emergency department information system; EV for physicians, a solution with ER-specific clinical c …
  • JFE Holdings, Inc. (5411):企業の財務・戦略的SWOT分析
    JFE Holdings, Inc. (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AMETEK Inc (AME)-医療機器分野:企業M&A・提携分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • Putnam Investments LLC:企業の戦略的SWOT分析
    Putnam Investments LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pharm-Olam International Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics subm …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • EDAP TMS SA (EDAP):医療機器:M&Aディール及び事業提携情報
    Summary EDAP TMS SA (EDAP) is a medical device company. It carries out the development, production and distribution of minimally invasive medical devices for the treatment of urological diseases. It offers High Intensity Focused Ultrasound (HIFU) devices for the treatment of localized prostate cance …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆